Literature DB >> 3530896

Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease.

J E Compston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530896      PMCID: PMC1433796          DOI: 10.1136/gut.27.9.1073

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  96 in total

1.  Effective 25-hydroxylation of vitamin D2 in alcoholic cirrhosis.

Authors:  D B Posner; R M Russell; S Absood; T B Connor; C Davis; L Martin; J B Williams; A H Norris; C Merchant
Journal:  Gastroenterology       Date:  1978-05       Impact factor: 22.682

2.  Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption.

Authors:  G R Thompson; B Lewis; C C Booth
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

3.  [Rarefactive osteosis in liver cirrhosis].

Authors:  L Collesson; J P Grilliat; J Mathieu; J Laurent
Journal:  Presse Med       Date:  1965-10-27       Impact factor: 1.228

4.  Plasma vitamin D-binding globulin in vitamin D deficiency, pregnancy and chronic liver disease.

Authors:  J M Barragry; D Corless; J Auton; N D Carter; R G Long; J D Maxwell; S Switala
Journal:  Clin Chim Acta       Date:  1978-08-01       Impact factor: 3.786

5.  The bones in chronic liver disease.

Authors:  C R Paterson; M S Losowsky
Journal:  Scand J Gastroenterol       Date:  1967       Impact factor: 2.423

6.  1,25-Dihydroxyvitamin D3 in childhood hepatic osteodystrophy.

Authors:  J E Heubi; R C Tsang; J J Steichen; G M Chan; I W Chen; H F DeLuca
Journal:  J Pediatr       Date:  1979-06       Impact factor: 4.406

7.  Osteomalacia, vitamin D deficiency and cholestasis in chronic liver disease.

Authors:  J B Dibble; P Sheridan; R Hampshire; G J Hardy; M S Losowsky
Journal:  Q J Med       Date:  1982

8.  Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis.

Authors:  O Epstein; Y Kato; R Dick; S Sherlock
Journal:  Am J Clin Nutr       Date:  1982-09       Impact factor: 7.045

9.  Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment.

Authors:  D S Matloff; M M Kaplan; R M Neer; M J Goldberg; W Bitman; H J Wolfe
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

View more
  29 in total

1.  Clinical benefits of biochemical markers of bone turnover in Egyptian children with chronic liver diseases.

Authors:  Karam A Mahdy; Hanaa H Ahmed; Fathia Mannaa; Azza Abdel-Shaheed
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

Review 2.  Hepatic osteodystrophy.

Authors:  Angelo Gatta; Alberto Verardo; Marco Di Pascoli; Sandro Giannini; Massimo Bolognesi
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

3.  Hormonal and cytokine implications in the pathophysiology of osteoporosis occurring in chronic liver diseases.

Authors:  Corina Lucaci; Monica Acalovschi
Journal:  Maedica (Buchar)       Date:  2012-12

4.  Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease.

Authors:  Jaividhya Dasarathy; Pranav Periyalwar; Sanath Allampati; Vikram Bhinder; Carol Hawkins; Patricia Brandt; Amer Khiyami; Arthur J McCullough; Srinivasan Dasarathy
Journal:  Liver Int       Date:  2013-10-01       Impact factor: 5.828

5.  Osteoporosis and skeletal fractures in chronic liver disease.

Authors:  T Diamond; D Stiel; M Lunzer; M Wilkinson; J Roche; S Posen
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

6.  Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection.

Authors:  Ingolf Schiefke; Andreas Fach; Marcus Wiedmann; Andreas-V Aretin; Eva Schenker; Gudrun Borte; Manfred Wiese; Joachim Moessner
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

7.  MELD score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease.

Authors:  Rebecca Mitchell; Jill McDermid; Mang M Ma; Constance L Chik
Journal:  World J Hepatol       Date:  2011-06-27

Review 8.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

9.  Prevalence of vitamin D deficiency in chronic liver disease.

Authors:  J Arteh; S Narra; S Nair
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

10.  The heterogeneity of bone disease in cirrhosis: a multivariate analysis.

Authors:  Bronwyn A L Crawford; C Kam; A J Donaghy; G W McCaughan
Journal:  Osteoporos Int       Date:  2003-09-19       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.